Cargando…

In vivo RyR1 reduction in muscle triggers a core-like myopathy

Mutations in the RYR1 gene, encoding the skeletal muscle calcium channel RyR1, lead to congenital myopathies, through expression of a channel with abnormal permeability and/or in reduced amount, but the direct functional whole organism consequences of exclusive reduction in RyR1 amount have never be...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelletier, Laurent, Petiot, Anne, Brocard, Julie, Giannesini, Benoit, Giovannini, Diane, Sanchez, Colline, Travard, Lauriane, Chivet, Mathilde, Beaufils, Mathilde, Kutchukian, Candice, Bendahan, David, Metzger, Daniel, Franzini Armstrong, Clara, Romero, Norma B., Rendu, John, Jacquemond, Vincent, Fauré, Julien, Marty, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657350/
https://www.ncbi.nlm.nih.gov/pubmed/33176865
http://dx.doi.org/10.1186/s40478-020-01068-4
_version_ 1783608483120152576
author Pelletier, Laurent
Petiot, Anne
Brocard, Julie
Giannesini, Benoit
Giovannini, Diane
Sanchez, Colline
Travard, Lauriane
Chivet, Mathilde
Beaufils, Mathilde
Kutchukian, Candice
Bendahan, David
Metzger, Daniel
Franzini Armstrong, Clara
Romero, Norma B.
Rendu, John
Jacquemond, Vincent
Fauré, Julien
Marty, Isabelle
author_facet Pelletier, Laurent
Petiot, Anne
Brocard, Julie
Giannesini, Benoit
Giovannini, Diane
Sanchez, Colline
Travard, Lauriane
Chivet, Mathilde
Beaufils, Mathilde
Kutchukian, Candice
Bendahan, David
Metzger, Daniel
Franzini Armstrong, Clara
Romero, Norma B.
Rendu, John
Jacquemond, Vincent
Fauré, Julien
Marty, Isabelle
author_sort Pelletier, Laurent
collection PubMed
description Mutations in the RYR1 gene, encoding the skeletal muscle calcium channel RyR1, lead to congenital myopathies, through expression of a channel with abnormal permeability and/or in reduced amount, but the direct functional whole organism consequences of exclusive reduction in RyR1 amount have never been studied. We have developed and characterized a mouse model with inducible muscle specific RYR1 deletion. Tamoxifen-induced recombination in the RYR1 gene at adult age resulted in a progressive reduction in the protein amount reaching a stable level of 50% of the initial amount, and was associated with a progressive muscle weakness and atrophy. Measurement of calcium fluxes in isolated muscle fibers demonstrated a reduction in the amplitude of RyR1-related calcium release mirroring the reduction in the protein amount. Alterations in the muscle structure were observed, with fibers atrophy, abnormal mitochondria distribution and membrane remodeling. An increase in the expression level of many proteins was observed, as well as an inhibition of the autophagy process. This model demonstrates that RyR1 reduction is sufficient to recapitulate most features of Central Core Disease, and accordingly similar alterations were observed in muscle biopsies from Dusty Core Disease patients (a subtype of Central Core Disease), pointing to common pathophysiological mechanisms related to RyR1 reduction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-020-01068-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7657350
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76573502020-11-13 In vivo RyR1 reduction in muscle triggers a core-like myopathy Pelletier, Laurent Petiot, Anne Brocard, Julie Giannesini, Benoit Giovannini, Diane Sanchez, Colline Travard, Lauriane Chivet, Mathilde Beaufils, Mathilde Kutchukian, Candice Bendahan, David Metzger, Daniel Franzini Armstrong, Clara Romero, Norma B. Rendu, John Jacquemond, Vincent Fauré, Julien Marty, Isabelle Acta Neuropathol Commun Research Mutations in the RYR1 gene, encoding the skeletal muscle calcium channel RyR1, lead to congenital myopathies, through expression of a channel with abnormal permeability and/or in reduced amount, but the direct functional whole organism consequences of exclusive reduction in RyR1 amount have never been studied. We have developed and characterized a mouse model with inducible muscle specific RYR1 deletion. Tamoxifen-induced recombination in the RYR1 gene at adult age resulted in a progressive reduction in the protein amount reaching a stable level of 50% of the initial amount, and was associated with a progressive muscle weakness and atrophy. Measurement of calcium fluxes in isolated muscle fibers demonstrated a reduction in the amplitude of RyR1-related calcium release mirroring the reduction in the protein amount. Alterations in the muscle structure were observed, with fibers atrophy, abnormal mitochondria distribution and membrane remodeling. An increase in the expression level of many proteins was observed, as well as an inhibition of the autophagy process. This model demonstrates that RyR1 reduction is sufficient to recapitulate most features of Central Core Disease, and accordingly similar alterations were observed in muscle biopsies from Dusty Core Disease patients (a subtype of Central Core Disease), pointing to common pathophysiological mechanisms related to RyR1 reduction. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-020-01068-4) contains supplementary material, which is available to authorized users. BioMed Central 2020-11-11 /pmc/articles/PMC7657350/ /pubmed/33176865 http://dx.doi.org/10.1186/s40478-020-01068-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pelletier, Laurent
Petiot, Anne
Brocard, Julie
Giannesini, Benoit
Giovannini, Diane
Sanchez, Colline
Travard, Lauriane
Chivet, Mathilde
Beaufils, Mathilde
Kutchukian, Candice
Bendahan, David
Metzger, Daniel
Franzini Armstrong, Clara
Romero, Norma B.
Rendu, John
Jacquemond, Vincent
Fauré, Julien
Marty, Isabelle
In vivo RyR1 reduction in muscle triggers a core-like myopathy
title In vivo RyR1 reduction in muscle triggers a core-like myopathy
title_full In vivo RyR1 reduction in muscle triggers a core-like myopathy
title_fullStr In vivo RyR1 reduction in muscle triggers a core-like myopathy
title_full_unstemmed In vivo RyR1 reduction in muscle triggers a core-like myopathy
title_short In vivo RyR1 reduction in muscle triggers a core-like myopathy
title_sort in vivo ryr1 reduction in muscle triggers a core-like myopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657350/
https://www.ncbi.nlm.nih.gov/pubmed/33176865
http://dx.doi.org/10.1186/s40478-020-01068-4
work_keys_str_mv AT pelletierlaurent invivoryr1reductioninmuscletriggersacorelikemyopathy
AT petiotanne invivoryr1reductioninmuscletriggersacorelikemyopathy
AT brocardjulie invivoryr1reductioninmuscletriggersacorelikemyopathy
AT giannesinibenoit invivoryr1reductioninmuscletriggersacorelikemyopathy
AT giovanninidiane invivoryr1reductioninmuscletriggersacorelikemyopathy
AT sanchezcolline invivoryr1reductioninmuscletriggersacorelikemyopathy
AT travardlauriane invivoryr1reductioninmuscletriggersacorelikemyopathy
AT chivetmathilde invivoryr1reductioninmuscletriggersacorelikemyopathy
AT beaufilsmathilde invivoryr1reductioninmuscletriggersacorelikemyopathy
AT kutchukiancandice invivoryr1reductioninmuscletriggersacorelikemyopathy
AT bendahandavid invivoryr1reductioninmuscletriggersacorelikemyopathy
AT metzgerdaniel invivoryr1reductioninmuscletriggersacorelikemyopathy
AT franziniarmstrongclara invivoryr1reductioninmuscletriggersacorelikemyopathy
AT romeronormab invivoryr1reductioninmuscletriggersacorelikemyopathy
AT rendujohn invivoryr1reductioninmuscletriggersacorelikemyopathy
AT jacquemondvincent invivoryr1reductioninmuscletriggersacorelikemyopathy
AT faurejulien invivoryr1reductioninmuscletriggersacorelikemyopathy
AT martyisabelle invivoryr1reductioninmuscletriggersacorelikemyopathy